economictimes.indiatimes.com ·
Societe General Prudential Others Buy 3 Per Cent Stake in Anthem Biosciences for Rs 1275 Cr

Executive Summary
AI-generatedGlobal investors, including Societe Generale and Prudential Hong Kong, acquired a combined 3% stake in Anthem Biosciences for approximately Rs 1,275 crore. The purchase was made from promoter Aruna Ganesh through open market transactions, with participation also coming from various domestic mutual funds and insurance companies. Following the deal, the promoters' collective holding in the company decreased to 71.63%.
This is a corporate action (institutional investment/stake acquisition) in Anthem Biosciences, a healthcare company listed on the NSE. The primary impact is on the stock price and promoter group's control/dilution, rather than a direct input cost or commodity channel. The transaction signals confidence from global financial institutions (Societe Generale, Prudential Hong Kong), potentially boosting investor sentiment for GLOBAL_HEALTHCARE stocks in India.
Key Insights
- Global investors led by Societe Generale and Prudential Hong Kong acquired a 3% stake in Anthem Biosciences.
- The total transaction value was reported at Rs 1,274.69 crore, purchased through open market transactions.
- Promoter Aruna Ganesh sold the shares, resulting in a reduction of promoter holdings from 74.68% to 71.63%.
- Numerous domestic institutional investors, including various mutual funds and insurance companies, participated in the deal.
Topic context
Related topics
The full article is on the original publisher site.